Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
Active, not recruiting · NCT05181592 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 3 | 2025-09-30 | NCT05181592 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Celgene | 53 |
| GWT-TUD GmbH | 2 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinica di Ematologia Istituto oncologico della Svizzera Italiana | Bellinzona | Switzerland | 1 |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | 5 |
| Hospital Universitario Central de Asturias | Oviedo | Spain | 40 |
| Hospital Universitario y Politecnico la Fe de Valencia | Valencia | Spain | 2 |
| Hospital Vall d´Hebron | Barcelona | Spain | 1 |
| Institut Català d' Oncologia de Badalona | Badalona | Spain | 1 |
| Klinikum rechts der Isar | München | Germany | 4 |
| Medizinische Universität Innsbruck | Innsbruck | Austria | 26 |
| Medizinische Universität Wien | Vienna | Austria | 43 |
| University Hospital of Salamanca | Salamanca | Spain | 4 |
| Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor | Bern | Switzerland | 1 |
| Universitätsklinikum Leipzig | Leipzig | Germany | 41 |
| Universitätsspital Basel | Basel | Switzerland | 43 |